Tonix Pharmaceuticals Holding Corp.
Last updated September 27, 2026
Organization details
- Legal name
- Tonix Pharmaceuticals Holding Corp.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- TNXP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001430306
Board of directors
-
Adeoye Y. Olukotun · DirectorSince 2023
-
Carolyn E. Taylor · DirectorSince 2023
-
David L. Grange · DirectorSince 2023
-
James Randolph Hunter Jr. · DirectorSince 2025
-
James Treco · DirectorSince 2023
-
Margaret Smith Bell · DirectorSince 2023
-
Richard H. Bagger · DirectorSince 2023
-
Richard Newcomb Stillwell · DirectorSince 2023
-
Seth Lederman · Director · Chief Executive OfficerSince 2023
Chief executives
Seth Lederman
· Chief Executive Officer
Dates unknown
Board connections
1 of this board's directors also sit on 1 other board.
- via Adeoye Y. Olukotun
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $418,578
- 5 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | SAENGER BRADLEY Officer (Chief Financial Officer) | Other | +1,453 | $10.91 | $15,858 |
| Jun 12, 2026 | Carolyn E. Taylor Director | Open-market purchase | +1,415 | $10.55 | $14,928 |
| Jun 9, 2026 | Seth Lederman Director, Officer (Chief Executive Officer) | Open-market purchase | +5,000 | $11.79 | $58,950 |
| Jun 8, 2026 | Richard Newcomb Stillwell Director | Open-market purchase | +5,000 | $11.65 | $58,250 |
| Mar 31, 2026 | Seth Lederman Director, Officer (Chief Executive Officer) | Open-market purchase | +5,000 | $12.62 | $63,100 |
| Mar 18, 2026 | Seth Lederman Director, Officer (Chief Executive Officer) | Open-market purchase | +15,000 | $14.89 | $223,350 |
| Dec 31, 2025 | SAENGER BRADLEY Officer (Chief Financial Officer), 10% owner | Grant or award | +701 | $13.42 | $9,407 |
| Aug 21, 2025 | Carolyn E. Taylor Director | Open-market purchase | +418 | $36.03 | $15,061 |
| Aug 20, 2025 | James Treco Director | Open-market purchase | +250 | $36.00 | $9,000 |
| May 15, 2025 | Seth Lederman Director, Officer (Chief Executive Officer) | Open-market purchase | +4,000 | $21.55 | $86,200 |
| Feb 5, 2025 | Margaret Smith Bell Director | Other | −1 | $0.15 | $0 |
| Feb 5, 2025 | James Treco Director | Other | −0 | $0.30 | $0 |
| Feb 5, 2025 | Richard H. Bagger Director | Other | −0 | $0.20 | $0 |
| Feb 5, 2025 | SAENGER BRADLEY Officer (Chief Financial Officer) | Other | −0 | — | — |
| Feb 5, 2025 | SULLIVAN GREGORY M Officer (Chief Medical Officer) | Other | −0 | $1.47 | $0 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.